BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9466358)

  • 1. Technetium-99m direct radiolabeling of monoclonal antibody ior egf/r3.
    Morales AA; Crespo FZ; Gandolff GN; Iznaga Escobar N; Pérez NP; Hernández JC
    Nucl Med Biol; 1998 Jan; 25(1):25-30. PubMed ID: 9466358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and comparative evaluation of 99mTc-labeled 2-iminothiolane modified antibodies and CITC-DTPA immunoconjugates of anti-EGF-receptor antibodies.
    Mishra AK; Iznaga-Escobar N; Figueredo R; Jain VK; Dwarakanath BS; Pérez-Rodríguez R; Sharma RK; Mathew TL
    Methods Find Exp Clin Pharmacol; 2002 Dec; 24(10):653-60. PubMed ID: 12616957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodistribution of 99mTc-labeled anti-human epidermal growth factor receptor (EGF-R) humanized monoclonal antibody h-R3 in a xenograft model of human lung adenocarcinoma.
    Morales-Morales A; Ducongé J; Caballero-Torres I; Núñez-Gandolff G; Fernández E; Iznaga-Escobar N
    Nucl Med Biol; 1999 Apr; 26(3):275-9. PubMed ID: 10363798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiolabeling and biological evaluation of DOTA-Ph-Al derivative conjugated to anti-EGFR antibody ior egf/r3 for targeted tumor imaging and therapy.
    Pnwar P; Iznaga-Escobar N; Mishra P; Srivastava V; Sharma RK; Chandra R; Mishra AK
    Cancer Biol Ther; 2005 Aug; 4(8):854-60. PubMed ID: 16082184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Direct and indirect labeling with 99mTc of an antireceptor monoclonal antibody of EGF].
    Calderón Sánchez O; Zayas Crespo F; Leyva Montaña R; Beckford Vera D; Gómez JA
    Rev Esp Med Nucl; 2005; 24(1):38-44. PubMed ID: 15701345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Freeze-dried formulation for direct 99mTc-labeling ior-egf/r3 MAb: additives, biodistribution, and stability.
    Morales AA; Núñez-Gandolff G; Pérez NP; Véliz BC; Caballero-Torres I; Ducongé J; Fernández E; Crespo FZ; Veloso A; Iznaga-Escobar N
    Nucl Med Biol; 1999 Aug; 26(6):717-23. PubMed ID: 10587113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics, biodistribution and dosimetry of 99mTc-labeled anti-human epidermal growth factor receptor humanized monoclonal antibody R3 in rats.
    Iznaga Escobar N; Morales AM; Ducongé J; Torres IC; Fernández E; Gómez JA
    Nucl Med Biol; 1998 Jan; 25(1):17-23. PubMed ID: 9466357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technetium-99m labelling of the IOR CEA 1 monoclonal antibody: evaluation of different methods.
    Gano L; Fernandes C; Cantinho G; Santos AI; Pena H; Vieira R; Salgado L; Patrício L
    Nuklearmedizin; 1997 Sep; 36(6):205-12. PubMed ID: 9380538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humanized versus murine anti-human epidermal growth factor receptor monoclonal antibodies for immunoscintigraphic studies.
    Morales AA; Ducongé J; Alvarez-Ruiz D; Becquer-Viart ML; Núñez-Gandolff G; Fernández E; Caballero-Torres I; Iznaga-Escobar N
    Nucl Med Biol; 2000 Feb; 27(2):199-206. PubMed ID: 10773550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a direct method for technetium labeling intact and F(ab')2 1A3, an anticolorectal monoclonal antibody.
    Schwarz SW; Connett JM; Anderson CJ; Rocque PA; Philpott GW; Guo LW; Welch MJ
    Nucl Med Biol; 1994 May; 21(4):619-26. PubMed ID: 9234319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 188Re-labeled anti-epidermal growth factor receptor humanized monoclonal antibody h-R3: labeling conditions, in vitro and in vivo stability.
    Iznaga-Escobar N; Ramirez IL; Izquierdo JC; Suárez L; Morales D; Pérez-Rodríguez R
    Methods Find Exp Clin Pharmacol; 2003 Nov; 25(9):703-11. PubMed ID: 14685297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Radiolabeling of a new agent for the study of colorectal tumors].
    Quesada Cepero W; Pimentel González G; Oliva González J; Pérez Tenorio G; Aguiar Cabeza E; Sánchez Monzón I; Hernández Romero O; Rebustillo Sierra M
    Rev Esp Med Nucl; 1998; 17(2):82-8. PubMed ID: 9611277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micromethod for quantification of SH groups generated after reduction of monoclonal antibodies.
    Iznaga Escobar N; Morales A; Núñez G
    Nucl Med Biol; 1996 Jul; 23(5):641-4. PubMed ID: 8905830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technetium-99m-labeled antibodies. Stability compared to 125I labeled antibodies.
    Gooden CS; Snook DE; Epenetos AA
    Cell Biophys; 1993; 22(1-3):49-59. PubMed ID: 7889542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct 99mTc labeling of monoclonal antibodies: radiolabeling and in vitro stability.
    Garron JY; Moinereau M; Pasqualini R; Saccavini JC
    Int J Rad Appl Instrum B; 1991; 18(7):695-703. PubMed ID: 1787078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct labeling of monoclonal antibodies with technetium-99m by photoactivation.
    Sykes TR; Woo TK; Baum RP; Qi P; Noujaim AA
    J Nucl Med; 1995 Oct; 36(10):1913-22. PubMed ID: 7562064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunoscintigraphy of intracranial glioma xenograft with a technetium-99m-labeled mouse monoclonal antibody specifically recognizing type III mutant epidermal growth factor receptor.
    Takasu S; Takahashi T; Okamoto S; Oriuchi N; Nakayashiki N; Okamoto K; Muramatsu H; Hayashi T; Nakahara N; Mizuno M; Wakabayashi T; Higuchi T; Endo K; Kozaki K; Miyaishi O; Saga S; Ueda R; Yoshida J; Yoshikawa K
    J Neurooncol; 2003 Jul; 63(3):247-56. PubMed ID: 12892230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioiodinated antibody targeting of the HER-2/neu oncoprotein: effects of labeling method on cellular processing and tissue distribution.
    Zalutsky MR; Xu FJ; Yu Y; Foulon CF; Zhao XG; Slade SK; Affleck DJ; Bast RC
    Nucl Med Biol; 1999 Oct; 26(7):781-90. PubMed ID: 10628557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radio-iodination of monoclonal antibody using potassium [125I]-(4-isothiocyanatobenzylammonio)-iodo-decahydro-closo-dodecaborate (iodo-DABI).
    Orlova A; Bruskin A; Sivaev I; Sjöberg S; Lundqvist H; Tolmachev V
    Anticancer Res; 2006; 26(2A):1217-23. PubMed ID: 16619527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor targeting using anti-epidermal growth factor receptor (ior egf/r3) immunoconjugate with a tetraaza macrocyclic agent (DO3A-EA).
    Mishra G; Panwar P; Mishra AK
    Mol Imaging; 2012; 11(5):408-16. PubMed ID: 22954185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.